In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease

Autoimmunity

Volumn 39, Issue 3, 2006, Pages 249-253

  La Corte, R ^a   Lo Mo Naco, A ^a   Locaputo, A ^a   Dolzani, F ^a   Trotta, F ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Anti Jo 1; Anti Ro SSA; Antisynthetase syndrome; Lung involvement

Indexed keywords

AUTOANTIBODY; RO ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTISYNTHETASE SYNDROME; ARTHRALGIA; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPHAGIA; DYSPNEA; EDEMA; ERYTHEMA; FEMALE; FEVER; FREQUENCY ANALYSIS; HUMAN; INTERSTITIAL LUNG DISEASE; MALE; MUSCLE WEAKNESS; MYALGIA; POLYMYOSITIS; PROGNOSIS; RAYNAUD PHENOMENON; SCORING SYSTEM; VASCULITIS; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOSITIS;

EID: 33745111226     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930600623791     Document Type: Article

References (32)

1. Bohan, A and Peter, JB. (1975) Polymyositis and dermatomyositis: Part 1 and 2 N Engl J Med, 292, pp. 344-347. 403-407
2. Wasicek, CA and Reichlin, M and Montes, M and Raghu, G. (1984) Polymyositis and interstitial lung disease in a patient with anti-Jo-1 prototype Am J Med, 76, pp. 538-544.
3. Nishikai, M and Reichlin, M. (1980) Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system Arthritis Rheum, 23, pp. 881-888.
4. Mathews, M and Bernstein, R. (1983) Myositis auto-antibodies inhibit histidyl-tRNA synthetase: A model for auto-immunity Nature, 83, pp. 304-317.
5. Margueire, C and Bunn, CC and Beynon, HL and Bernstein, RM and Hughes, JM and So, AK and et al. (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes Q J Med, 77, pp. 1019-1038.
6. Yoshida, S and Akizuki, M and Mimori, T and Yamagata, H and Inada, S and Homma, M. (1983) The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis Arthritis Rheum, 26, pp. 604-611.
7. Masseau, AI and Hamidou, M and Agard, C and Grolleau, JY and Cherin, P. (2003) Antisynthetase syndrome J Bone Spine, 70, pp. 161-168.
8. Marie, I and Hachulla, E and Cherin, P and et al (2002) Interstitial lung disease in polymyositis and dermatomyositis Arthritis Rheum, 47, pp. 614-622.
9. Douglas, WW and Tazelaar, HD and Hartman, TE and Hartman, RP and Decker, PA and Schroder, DR and Ryu, JH. (2001) Polymyositis-dermatomyositis associated interstitial lung disease Am J Respir Crit Care Med, 164, pp. 1182-1185.
10. Warrick, JH and Bhalla, M and Schabel, SI and Silver, RM. (1991) High resolution tomography in early systemic sclerosis J Rheumatol, 18, pp. 1520-1528.
11. Diot, E and Boissinot, E and Asquier, E and Guilmot, JL and Lemarie, E and Valat, C and Diot, P. (1998) Relationship between abnormalities on high-resolution CT and the pulmonary function in systemic sclerosis Chest, 114, pp. 152028.
12. Quanjer, PH and Tammeling, GJ and Cotes, JE and Pedersen, OF and Peslin, R and Yernault, JC. (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal Official Statement of the European Respiratory Society Eur Respir J, 6(Suppl. 16), pp. 5-40.
13. Cotes, JE and Chinn, DJ and Quanjer, PhH and Roca, J and Yernault, JC. (1993) Standardization of the measurement of transfer factor (diffusing capacity) Eur Respir J, 6(Suppl. 16), pp. 41-52.
14. Vitali, C and Bombardieri, S and Jonson, R and Moutsopoulos, HM and Alexander, EL and Carsons, SE and Daniels, TE and Fox, PC and Kassan, SS and Pillemer, SR and Tala, N and Weisman, MH. (2002) Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European consensus group Ann Rheum Dis, 61, pp. 544-548.
15. Oddis, CV and Conte, CG and Steen, VD and et al (1990) Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny county, PA 1963-1982 J Rheumatol, 17, pp. 1329-1334.
16. Medsger, TA, Jr and Dawson, WN, Jr and Masi, AT. (1970) The epidemiology of polymyositis Am J Rheumatol, 48, pp. 715-723.
17. Patrick, M and Buckbinder, R and Jolley, D and et al (1999) Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering J Rheumatol, 26, pp. 1094-1100.
18. Spath, M and Schroder, M and Schlotter-Weigel, B and Walter, MC and Hautmann, H and Leinsinger, G and Pongratz, D and Muller-Felber, W. (2004) The long-term outcome of anti-Jo-1-positive inflammatory myopathies J Neurol, 251, pp. 859-864.
19. Love, LA and Leff, RL and Fraser, DD and Targoff, IN and Dalakas, M and Plotz, PH and et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogenous patient group Medicine (Baltimore), 70, pp. 360-374.
20. Reichlin, M and Arnett, FC, Jr. (1984) Multiplicity of autoantibodies in myositis sera Arthritis Rheum, 27, pp. 1150-1156.
21. Hirakata, M and Mimori, T and Akizuki, M and Craft, J and Hardin, JA and Homma, M. (1992) Autoantibodies to a small nuclear and cytoplasmic ribonucleoproteins in Japanes patients with inflammatory muscle disease Arthritis Rheum, 35, pp. 449-456.
22. Mimori, T. (1996) Structures targeted by the immune system in myositis Curr Opin Rheumatol, 8, pp. 521-527.
23. Targoff, IN. (1994) Immune manifestations in inflammatory muscle disease Rheum Dis Clin N Am, 20, pp. 857-880.
24. Hausmanowa-Petrusewicz, I and Kowalska-Oledzka, E and Miller, F and et al (1992) Clinical, serological and immunogenetic features of polish patients with idiopathic inflammatory myopathies Arthritis Rheum, 40, pp. 1257-1266.
25. Zampieri, S and Ghirardello, A and Iaccarino, L and Tarricone, E and Gambari, PF and Doria, A. (2005) Anti-Jo-1 antibodies Autoimmunity, 38, pp. 73-78.
26. Selva-O'Callaghan, A and Labrador-Horrillo, M and Mum̃oz-Gall, X and Martìnez-Gomez, X and Majò-Masferrer, J and Solans-Laque, R and Simeon-Aznar, CP and Morell-Brotard, F and Vilardel-Tarres, M. (2005) Polymyositis/dermatomyositis-associated lung disease: Analysis of a series of 81 patients Lupus, 14, pp. 534-542.
27. Fathi, M and Dastmalchi, M and Rasmussen, E and et al (2004) Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis Ann Rheum Dis, 63, pp. 297-301.
28. Marie, I and Hachulla, E and Chérin, P and et al (2002) Interstitial lung disease in polymyositis and dermatomyositis Arthritis Rheum, 47, pp. 614-622.
29. Targoff, IN and Miller, FW and Medsger, TA, Jr and Oddis, CV. (1997) Classification criteria for the inflammatory myopathies Curr Opin Rheumatol, 9, pp. 527-535.
30. Greenwald, R and Tashkin, DP and Gong, H and et al (1987) Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis Am J Med, 83, pp. 83-92.
31. Steen, V and Conte, C and Owens, GR and et al (1994) Severe restrictive disease in systemic sclerosis Arthritis Rheum, 37, pp. 1283-1289.
32. Steen, V. (2003) Predictors of end stage lung disease in systemic sclerosis Ann Rheum Dis, 62, pp. 97-99. [editorial]